Pay in 4 interest-free payments of $5.95 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
One is Virta Health, which advertises its nutrition-focused weight management program as a proven approach for deprescribing GLP-1s when clinically appropriate. A Virta-funded study assessed 154 people with Type 2 diabetes who stopped using GLP-1 medications but continued following Virtas program, concluding that their weight did not significantly increase after a year
PMID: 26771670
Supplementary Data 1 (download ZIP Atomic coordinates for starting, ending and selected time-points of MD simulations
During screening, only articles with a functional neurocognitive or behavioral outcome were included
This ratio of fat-to-lean mass reduction is consistent with established obesity therapies and suggests that metabolic function is preserved during weight loss
Liposomes are tiny phospholipid bubbles-biocompatible, cell-friendly carriers that mimic your natural cell membranes
![Classification of GLP-1 RAs based on different parameters [13]](https://www.researchgate.net/publication/343265981/figure/tbl1/AS:923164464906240@1597110968484/Classification-of-GLP-1-RAs-based-on-different-parameters-13.png)
